Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Goodman

Showing results (571-580 of 582) with videos related to

Pageof 59
Sort By:
Journal of the National Cancer Institute|November 21, 2015
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong D Meeks, Honglin Song, Kyriaki Michailidou, et al.
European Journal of Human Genetics : EJHG|January 14, 2022
Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
Nature Communications|September 9, 2025
Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locusKate Lawrenson, Siddhartha Kar, Karen McCue, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Nature Communications|September 8, 2016
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locusKate Lawrenson, Siddhartha Kar, Karen McCue, et al.
European Journal of Human Genetics : EJHG|March 22, 2022
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
Nature Communications|January 27, 2019
Shared heritability and functional enrichment across six solid cancersXia Jiang, Hilary K Finucane, Fredrick R Schumacher, et al.
Nature Communications|September 25, 2019
Publisher Correction: Shared heritability and functional enrichment across six solid cancersXia Jiang, Hilary K Finucane, Fredrick R Schumacher, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Pageof 59

Showing results (571-580 of 582) with videos related to

Sort By:
Pageof 59
Journal of the National Cancer Institute|November 21, 2015
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong D Meeks, Honglin Song, Kyriaki Michailidou, et al.
European Journal of Human Genetics : EJHG|January 14, 2022
Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
Nature Communications|September 9, 2025
Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locusKate Lawrenson, Siddhartha Kar, Karen McCue, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Nature Communications|September 8, 2016
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locusKate Lawrenson, Siddhartha Kar, Karen McCue, et al.
European Journal of Human Genetics : EJHG|March 22, 2022
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
Nature Communications|January 27, 2019
Shared heritability and functional enrichment across six solid cancersXia Jiang, Hilary K Finucane, Fredrick R Schumacher, et al.
Nature Communications|September 25, 2019
Publisher Correction: Shared heritability and functional enrichment across six solid cancersXia Jiang, Hilary K Finucane, Fredrick R Schumacher, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Pageof 59